BioXcel Therapeutics, Inc.
BTAI
$4.98
-$0.25-4.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.02% | -58.17% | -54.23% | -55.11% | -55.88% |
| Total Receivables | -97.91% | -- | 84.51% | -99.59% | 88.40% |
| Inventory | -81.12% | -73.68% | -65.90% | -24.43% | 39.22% |
| Prepaid Expenses | 85.59% | 125.25% | 90.15% | 16.25% | -24.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.95% | -25.38% | -30.70% | -35.61% | -64.56% |
| Total Current Assets | -60.67% | -53.31% | -48.17% | -51.60% | -53.57% |
|
|
|||||
| Total Current Assets | -60.67% | -53.31% | -48.17% | -51.60% | -53.57% |
| Net Property, Plant & Equipment | -53.21% | -46.78% | -41.78% | -37.62% | -34.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -60.59% | -53.15% | -47.98% | -51.33% | -53.29% |
|
|
|||||
| Total Accounts Payable | 25.92% | -10.28% | 17.11% | 39.55% | 18.33% |
| Total Accrued Expenses | -62.18% | -72.33% | -56.06% | -69.03% | -41.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,077.84% | 1,587.82% | -- | 8.55% | 8.73% |
| Total Finance Division Other Current Liabilities | -38.98% | 71.64% | -80.30% | 135.51% | -33.21% |
| Total Other Current Liabilities | -38.98% | 71.64% | -80.30% | 135.51% | -33.21% |
| Total Current Liabilities | 22.31% | -18.85% | -18.46% | -35.15% | -21.46% |
|
|
|||||
| Total Current Liabilities | 22.31% | -18.85% | -18.46% | -35.15% | -21.46% |
| Long-Term Debt | -5.38% | -1.69% | 1.90% | 5.40% | 6.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -85.23% | -69.57% | -58.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -71.58% | -84.57% | 248.19% | 115.44% | 353.41% |
| Total Liabilities | -4.49% | -16.77% | 0.94% | -4.63% | 4.10% |
|
|
|||||
| Common Stock & APIC | 3.19% | 4.08% | 4.31% | 4.92% | 5.28% |
| Retained Earnings | -8.14% | -6.49% | -10.09% | -12.49% | -20.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -44.91% | -24.61% | -64.76% | -110.88% | -1,367.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.91% | -24.61% | -64.76% | -110.88% | -1,367.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.91% | -24.61% | -64.76% | -110.88% | -1,367.07% |
|
|
|||||